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To quantify the amount of the 3460G3A/ND1 point
mutation responsible for Leber’s hereditary optic
neuropathy, we developed a quantitative real-time
polymerase chain reaction method based on the SYBR
Green assay and a new approach using the TaqMan
assay. Both methods were based on the amplification
refractory mutation system, comparing the hetero-
plasmic load quantified by restriction fragment
length polymorphism in 15 Leber’s hereditary optic
neuropathy family members, with the results ob-
tained using quantitative real-time polymerase chain
reaction methods. The comparative evaluation of mi-
tochondrial DNA (mtDNA) heteroplasmy from blood
samples showed significant correlation between re-
striction fragment length polymorphism analysis, re-
al-time SYBR Green assay, and TaqMan assay. We val-
idated the last method by measuring experimental
samples composed by a known proportion of cloned
plasmids containing either the wild-type or mutant
sequence, giving a correlation coefficient of 0.999
(P < 0.0001). The real-time amplification refractory
mutation system polymerase chain reaction by Taq-
Man assay provides a rapid, reliable, sensitive, repro-
ducible, and one-step quantitative method to detect
heteroplasmic mutant mtDNA. This method allows
the quantitation of a broad range of mutational load
(up to 100%, down to 0.01%) on the basis of in vitro
calibration, thus rendering the TaqMan assay suitable
for the diagnostic analysis of heteroplasmic load in
mtDNA-related disorders. (J Mol Diagn 2007, 9:538–545;
DOI: 10.2353/jmoldx.2007.060183)
Mitochondria, the main source of energy within cells,
contain their own genome. The mitochondrial DNA
(mtDNA), which is a double-stranded circular intronless
DNA, contains genes encoding subunits of the respira-
tory chain as well as genes for tRNAs and rRNAs. Muta-
tions in mtDNA are responsible for mitochondrial en-
cephalomyopathies, a group of maternally inherited
disorders characterized by impaired energy production.
Mutations in nuclear DNA also account for mitochondrial
disorders, being mostly of the subunits of the mitochon-
drial respiratory chain complexes encoded by the nu-
clear genome; the intergenomic signaling and regulatory
role of nuclear proteins on mitochondrial function are
further aspects of nuclear involvement in mitochondrial
dysfunction.
Leber’s hereditary optic neuropathy (LHON; Online
Mendelian Inheritance of Man no. 535000) is a maternally
inherited disorder characterized by a primary degenera-
tion of the retinal ganglion cells followed by optic nerve
atrophy.1 Central vision is mostly affected because of the
preferential death of the small nerve fibers of the papil-
lomacular bundle.2 Several mitochondrial mutations are
proposed to be involved in disease development, but
most cases are associated with one of three mtDNA point
mutations, 3460G3A/MT-ND1, 11778G3A/MT-ND4,
and 14484T3C/MT-ND6, which are responsible for ap-
proximately 90% of LHON cases worldwide. These three
very frequent mtDNA point mutations are considered pri-
mary, and they affect genes coding for different subunits
of complex I with modest or subtle biochemical signa-
tures in complex I function. The 3460G3A mutation af-
fects the ND1 subunit, and this mutation has been con-
sistently found to result in a 60 to 80% reduction in
complex I-specific activity in a variety of tissues such as
patient platelets, fibroblasts, and lymphoblasts.3
According to the peculiar rules of mitochondrial genet-
ics, LHON is maternally inherited, and most LHON fami-
lies carry the mtDNA mutation in the homoplasmic con-
dition, but only a subset of individuals becomes blind
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(incomplete penetrance). These individuals are fre-
quently grouped in some pedigree branches.4 Moreover,
LHON mostly affects young males, which cannot be ex-
plained solely on the basis of the mtDNA mutations.1
Thus, LHON differs from other mitochondrial diseases
because it is associated with a homoplasmic mtDNA
mutation, it has a male prevalence, and it shows an
incomplete and variable penetrance. The existence of
further genetic determinants, such as nuclear modifying
genes5 possibly on chromosome X, has been largely
debated.6 The most compelling evidence for a modifying
role comes from the association of mtDNA haplogroup J
with the 11778G3A and 14484T3C, which possibly
increases LHON penetrance. On the contrary, there is no
explanation for why the 3460G3A mutation is distributed
in all haplogroups at frequencies similar to the control
population.7,8 Most probably this is because of the bio-
chemical severity of this mutation and the capability of
clinical expression without the modifying intervention of
mtDNA haplogroups. In fact, this mutation also has the
lowest male/female ratio and is most frequently found
heteroplasmic, as in the case of more severe mtDNA
mutations.1 Thus, the availability of a reliable quantitative
method for evaluation of heteroplasmy is particularly rel-
evant for the 3460G3A mutation to study its somatic and
germline segregation in patients and families.
The traditional approach in determining heteroplasmic
load in mtDNA point mutation-related disorders is the
polymerase chain reaction (PCR) amplification of the
DNA fragment containing the mutation, followed by re-
striction fragment length polymorphism (RFLP) analysis
and subsequent detection through ethidium bromide-
stained agarose gel or polyacrylamide separation in the
presence of radiolabeled deoxynucleotide in the PCR.
The detection limit for RFLP-ethidium bromide is approx-
imately 5 to 10%, whereas that for the radioactive method
is between 2 and 5%.9
It is clear that a more sensitive method is required to
detect lower amounts of mutation in pedigrees. A repro-
ducible method that avoids the use of radioactively la-
beled nucleotides, a more sensitive approach that could
lower the detection limit, and a specific method that
allows a clear quantification of both mtDNA populations
are the main characteristics of the method that should be
developed for our purposes.
In the present study, we developed a real-time quan-
titative PCR technique to quantify the mutational load of
the 3460G3A mutation. The method is based on an
“amplification refractory mutation system” (ARMS),10 and
it was first applied on a quantitative assay in the presence
of SYBR Green to set up primer specificity. After this
approach, we designed a labeled probe for TaqMan
assay to increase the specificity of the quantitative PCR.
We showed some differences between the use of a fluo-
rescent intercalator such as SYBR Green and the use of
a TaqMan probe of heteroplasmic mtDNA mutants. The
results demonstrate that the real-time assay is a rapid,
sensitive, and reliable method that can replace RFLP
analysis in detection and quantification.
Materials and Methods
Patients, DNA Sources, and DNA Isolation
Venous blood samples were obtained, after informed
consent and institutional approval of the Department of
Neurological Sciences of Bologna University, from a male
LHON proband homoplasmic for the 3460G3A mutation
and from further maternally related individuals of both
healthy or affected carriers of the 3460G3A/MT-ND1
mutation (Figure 1). In total, 15 family members (eight
males and seven females) were included in this study.
Only two males (IV-1 and V-3) and two females (III-3 and
III-21) presented with visual loss with the typical hall-
marks of LHON.
The pedigree has been previously studied as pedigree
48; it has also been evaluated spectroscopically11 and
biochemically (as family 4).12 In all of the previous stud-
ies, the DNA from the same blood withdrawals used in
Figure 1. Pedigree of the 3460G3A/ND1 LHON family analyzed in this study. Proband position in the pedigree is indicated by an arrow. For
all members, the position of the generation and family is indicated. The age of each member is reported at the time of blood sampling.
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these experiments has been evaluated by PCR/RFLP.
Total DNA was isolated from peripheral blood by using
proteinase K digestion followed by standard phenol-
chloroform extraction and ethanol precipitation.12
Quantitative Detection of mtDNA with a
3460G3A/ND1 Point Mutation: Primers
for ARMS
For the amplification refractory method approach, a set of
PCR primers with a sequence matched to the mutated
mtDNA at the 3 end was used for selective amplification
of the mutated mtDNA. Another set of primers was aimed
to amplify selectively wild-type molecules, whereas a
third set of primers was designed to amplify total mtDNA
(wild-type plus mutated molecules). The primers were
designed using Primer Express software (Applied Bio-
systems, Foster City, CA), and Table 1 reports their am-
plification targets and sequence with nucleotide positions
referred to the mtDNA sequence.13 Primer specificity has
been tested by gradient PCR (Eppendorf-5 Prime, Inc.,
Boulder, CO) to achieve the best yield and specificity at
the most suitable annealing temperature (60°C) to set up
a real-time PCR assay.
Quantitative Assay Using SYBR Green
The total amount of master mixture contained SYBR
Green dye (Applied Biosystems) with AmpliTaq Gold
DNA polymerase, dNTPs, and dUTP, and MgCl2 was
used according to manufacturer’s protocols. Reactions
also contained 100 nmol/L each of the forward and re-
verse primers for amplification of mutant and wild-type
mtDNA and 200 nmol/L each of the forward and reverse
primers for total mtDNA amplification, a range of 5 to 100
ng of total DNA in a final volume of 25 l. Real-time PCR
conditions were 2 minutes at 50°C and 10 minutes at
95°C, followed by 40 cycles of denaturation for 15 sec-
onds at 95°C and annealing/extension for 60 seconds at
60°C. The PCR products were quantified with an auto-
matic sequence detection system (ABI Prism 7700; Ap-
plied Biosystems) at each step of amplification using the
SDS software (version 1.0; Applied Biosystems).
Quantification Using TaqMan Assay
An alternative approach to quantify heteroplasmic load is
represented by the TaqMan assay.14 The nucleotide se-
quence of the minor groove binder (MGB) TaqMan probe
was 5-FAM-TATATACAACTACGCAAAGGC-3 (3394 to
3414). The melting temperature of 71°C for this probe is
ideal for use with the sets of primers with the annealing
temperature of 60°C, designed by us according to the
manufacturer’s protocol (Primer Express; Applied Biosys-
tems), which suggests an annealing temperature for the
TaqMan MGB probe at least 10°C higher than the primers
annealing temperature.
PCR started at 95°C for 15 seconds, followed by 40
cycles at 95°C for 15 seconds and 60°C for 60 seconds.
The reaction mixture (25 l) contained template DNA (5
ng), TaqMan Universal PCR Master Mix (2 composed of
DNA polymerase AmpliTaq Gold), AmpErase UNG (ura-
cil N-glycosylase), dNTPs with dUTP, and appropriate
MgCl2 concentrations according to the Applied Biosys-
tems data sheet, 200 nmol/L TaqMan probe, and 200
nmol/L of each of the forward and reverse primers for
quantifying total mtDNA or 100 nmol/L of each primer for
quantifying mutant and wild-type mtDNA. The PCR prod-
ucts were quantified the same way as SYBR Green
amplicons.
Assay Calibration
For mtDNA quantification by PCR analysis, we generated
calibration curves with serial dilutions of the target se-
quence PCR products. Three different mtDNA amplicons
were produced and inserted in a pGEM-T Easy Vector
(Promega, Charbonnie`res, France), thus creating three
different plasmids. One plasmid contained 3460G (wild-
type), whereas another contained 3460A (mutant), both
encompassing nucleotides 3291 to 3478. These plas-
mids were used for the calibration of wild-type and mu-
tant mtDNA populations. The third plasmid was created
by inserting an mtDNA sequence from nucleotides 3291
to 3517, and this plasmid was used as a calibrator for
total mtDNA (mutant  wild-type).
Plasmid DNA was isolated and purified with the Fast
Plasmid Mini kit (Eppendorf) according to the manufac-
turer’s protocol. The plasmid copy number was deter-
mined by dividing the total DNA concentration by the
weight of each plasmid molecule. Both mutant and wild-
type plasmid vectors had the same size (3015 and 3014
bp, respectively); thus, the weight of double-stranded
mtDNA molecule (ie, for the mutant plasmid) was esti-
mated as follows: [(3.015 kb  amplicon kb)MWt]/A,
where MWt denotes the molecular weight of 1 kb of
double-stranded DNA (6.6  105 g/mol), and A denotes
Avogadro’s number (6.02  1023 molecules/mol).15
Table 1. Real-Time PCR Primers
Amplification product Nucleotide position Oligonucleotide sequence Amplicon size (bp)
Mutant molecules 3291 to 3311 5-TCCTCTTCTTAACAACATACC-3 188
3478 to 3460 5-TGGTGAAGAGTTTTATGGT-3
Wild-type molecules 3291 to 3311 5-TCCTCTTCTTAACAACATACC-3 187
3477 to 3460 5-GGTGAAGAGTTTTATGGC-3
Total mtDNA 3291 to 3311 5-TCCTCTTCTTAACAACATACC-3 227
3517 to 3499 5-AGAGGGTGATGGTAGATGT-3
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Regarding relative quantification, Ct (threshold cycle)
of target sequences (mutant or wild-type) were related to
Ct of total sequence (mutant  wild-type) used as a
normalizer. The 2Ct values were obtained by serial
dilutions of mutant and wild-type plasmid DNA. Data
were obtained by averaging three independent
experiments.
RFLP Analysis
The RFLP quantitative analysis was performed using the
protocol previously described.11
Results
Development of a Method for Quantifying the
Amount of 3460G3A Point Mutation in mtDNA
Because LHON mutation at nt3460 could be present in
low percentages in patients, we developed a method to
detect and quantify small amounts of mutant mtDNA.
Under the strict PCR conditions described in the previous
section, only three sets of primers were selective and
specific enough to amplify the target mtDNA region 3460
according to the universal parameters of Applied Biosys-
tems reagents. The amplified DNA fragment was de-
tected by electrophoresis on agarose gel, and it was
confirmed to be the corresponding mtDNA region by
sequencing (data not shown). The absence of amplified
band from 0 cell line DNA (devoid of mtDNA) subjected
to PCR cycling with the three sets of primers excluded
nuclear pseudogene amplification.
In the experimental design, we selected allele-specific
primers modified only at the 3 end without adding any
mismatch near the 3 end. Such allele-specific primers
have been tested, together with other sets of primers, by
using gradient PCR to choose the best sets of primers
giving a high amount of specific products working at the
highest annealing temperature. The purpose of this kind
of choice is to design a TaqMan-based quantitative real-
time PCR method by using SYBR Green assay to set up
PCR conditions. Moreover, the TaqMan probe had to be
designed to be annealed at a temperature of over 70°C,
at least 10°C higher than the annealing temperature of
the primers.
Quantification of Heteroplasmy Using
SYBR Green
Regarding quantitative analysis, we first detected the
optimal concentrations of primers according to the uni-
versal protocol using fluorogenic SYBR Green. The opti-
mum concentration of 100 nmol/L provided a low Ct and
high Rn (defined as the magnitude of the fluorescence
signal generated during the PCR at each time point)
when using the sets of primers for the amplification of
wild-type and mutated molecules. The optimum concen-
tration for the total mtDNA amplification was 200 nmol/L.
These optimized primer concentrations amplified specific
amplicons of the mtDNA 3460 region. To assess the
efficiency of real-time SYBR Green assay, calibration
curves were generated from duplicate amplification of
three independent serial dilutions of the cloned plasmid
mtDNA 3460 region PCR products. These curves were
obtained from Ct values plotted against the logarithm of
plasmid copy number. There was a good correlation
between the cycle number and mtDNA copy number with
correlation coefficients (slopes) of 3.486 for mutated
and total copies of primers and 3.719 for wild-type
primers. The corresponding amplification efficiencies, 94
and 86%, calculated on the basis of the formula Eff 
10(1/slope) 1,16 were in an acceptable range in favor of
the specificity of amplicons obtained in real-time PCR
with the selected copies of primers according to stan-
dard SYBR Green assay.
This optimized SYBR Green assay was applied to re-
analyze samples to quantify 3460G3A in mtDNA in the
individuals of the pedigree. The mean Ct values of am-
plification by total primers were used as normalizer, thus
giving Ct, whereas the Ct of mutant and wild-type
Table 2. Heteroplasmic Load Obtained with PCR/RFLP, Real-Time PCR Using SYBR Green, and Real-Time PCR Using TaqMan
MGB Probe
Sample % PCR/RFLP
% SYBR Green
(error range)*
% TaqMan
(error range)*
III-1 56 64.7 (57.9 to 71.5) 89.2 (88.2 to 90.2)
III-2 0 0 (0 to 0) 0 (0 to 0)
III-3 100 88.7 (80.8 to 96.7) 100 (100 to 100)
III-5 22 5.5 (4.8 to 6.2) 7 (5.2 to 8.8)
III-7 19 5.2 (4.9 to 5.6) 46.8 (44.6 to 49)
III-8 17 2 (0.6 to 3.4) 21 (20.1 to 21.9)
III-9 100 90 (90 to 90) 100 (100 to 100)
III-21 100 91 (89.6 to 91.4) 100 (100 to 100)
IV-1 100 85 (77.9 to 92.1) 100 (100 to 100)
IV-2 100 99.5 (98.8 to 100.2) 100 (100 to 100)
IV-3 100 75 (67.5 to 82.1) 100 (100 to 100)
IV-7 66 57 (54.2 to 59.8) 74.5 (73.7 to 75.3)
V-1 74 85 (77.7 to 93.3) 90.3 (89.3 to 91.3)
V-2 100 60 (60 to 60) 100 (100 to 100)
V-3 100 81.2 (79.3 to 81.3) 99.8 (99.4 to 100.2)
*Mean and error range (1 SD) are obtained from three independent experiments.
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plasmids (at a concentration of 2.6  1014 copies/ml)
was used as a calibrator (Ct).17 Results are reported in
Table 2. The correlation coefficient (R2) for RFLP versus
real-time PCR proportion of mutant mtDNA was 0.942
(P 	 0.0001).
Quantification of Heteroplasmy Using
TaqMan Probe
After the SYBR Green approach, we tested primer ampli-
fication protocols and designed a labeled probe to am-
plify samples by TaqMan assay. The probe was labeled
with 6-carboxyfluorescein at the 5 end with a melting
temperature of approximately 71°C, 10°C higher than the
primer melting temperature, and it was designed as an
MGB probe, which binds to the minor groove of the
double-stranded DNA. Calibration curves showed good
correlation between the cycle number and mtDNA copy
number with correlation coefficients of 3.411, 3.412,
and 3.305 for mutant, wild-type, and total copies of
primers, respectively, demonstrating a good efficiency
(96 to 100%) of amplification reaction using tested prim-
ers according to the selected conditions in the SYBR
Green assay (Figure 2).
For method validation, we mixed known amounts of the
wild-type and mutant mtDNA to obtain 12 samples con-
taining various proportions of mutant mtDNA. Results of
TaqMan assay PCR are shown in Figure 3. The correla-
tion coefficient for the observed versus expected propor-
tion of mutant was 0.99863. A proportion of mutant
mtDNA as low as 0.01% was detected by this method.
We re-analyzed our samples by real-time TaqMan as-
say to quantify 3460G3A in mtDNA of LHON patients.
The Ct values of amplification by total primers were used
as a normalizer (Ct), and a starting concentration of
2.6  1014 copies/ml of plasmids harboring the 3460
region mtDNA was used as a calibrator (Ct).17 Results
are reported in Table 2. The correlation coefficient (R2) for
RFLP versus TaqMan assay proportion of mutant mtDNA
was 0.949 (P 	 0.0001).
Discussion
Point mutations can be present in mtDNA either in a
homoplasmic (all mtDNA molecules carry the mutation)
or heteroplasmic (coexistence of mutant and wild-type
mtDNA molecules) fashion. The conventional approach
Figure 2. Calibration curves of mtDNA amplification obtained by serial
dilutions of plasmids using TaqMan MGB probe. A: Calibration curve of
mutant mtDNA; B: calibration curve of wild-type mtDNA; and C: calibration
curve of total mtDNA. Slopes of each calibration curve with the correspond-
ing calculated efficiency and correlation coefficients (R2) are reported for
each set of primers.
Figure 3. Correlation of expected and observed percentages of 3460G3A
mutant mtDNA by real-time ARMS-PCR analysis, using TaqMan assay, of 12
samples containing various proportions of mutant mtDNA. Equation for the
line: y  1.02x  1.06%.
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for the quantitation of heteroplasmic mtDNA mutations
involves PCR/RFLP analysis usually performed after the
“hot last cycle” to avoid the formation of heteroduplexes
affecting quantitation after digestion.18 This method is
time-consuming, including PCR amplification, introduc-
tion of radiolabeled deoxynucleotides, digestion with re-
striction endonuclease, polyacrylamide gel electrophore-
sis, and quantitation through radioactive signal intensity.
Moreover, incomplete digestion with restriction endonu-
clease could affect the final result.
The most reliable alternative approach to quantify het-
eroplasmy is represented by real-time PCR. This method
has been successfully applied in quantitation of total
mtDNA19,20 and mtDNA deletions.21 Quantitative analy-
sis of heteroplasmic mtDNA mutation has been per-
formed by several groups using SYBR Green and ARMS
amplification,9 hydrolysis probes,22 or Molecular Bea-
cons.23 Furthermore, new quantitative real-time PCR
approaches involved the use of specific TaqMan
probes to discriminate wild-type and mutant mtDNA
molecules.24,25
The application of different methods to quantify the
mutational load in mtDNA disorders also includes meth-
ods based on pyrosequencing and SnapShot tech-
nology.26,27 Heteroplasmic load in families harboring the
3460G3A has also been successfully investigated by
using the primer extension technology.28 Fastness and
reliability are the main characteristics requested for new
methods, thus implying the use of single-tube tests or
reproducible and standardized methods similar to radio-
labeled PCR/RFLP.
The ARMS technique to amplify selectively wild-type
and mutant molecules has been extensively used, thus
contributing to the development of newer applications.
The choice of using appropriate primers and selective
amplification protocols does not eliminate the inconve-
nience of nonspecific amplifications, thus limiting the dy-
namic range of ARMS allele-specific real-time PCR assay
because of the late-cycle amplification of the nontarget
allele.29 By using ARMS real-time PCR in the presence of
SYBR Green, we met this inconvenience by amplifying in
nonspecific mode the mutant plasmid using wild-type-
specific primers. Even if our nonspecific amplification
occurred and shifted 12 cycles after the specific ampli-
fications, we did not observe the same nonspecific am-
plification in the presence of TaqMan probe, by using the
same set of primers in the presence of the same target
molecules. We designed primers for the TaqMan assay,
considering that additional mismatched nucleotides be-
fore the 3 end of the primer have an inhibitory effect on
PCR efficiency and act to delay the generation of both
specific and nonspecific PCR products; this can be use-
ful in enabling a PCR to be stopped at a certain time point
(ie, 30 cycles), where specific PCR products have been
generated but nonspecific PCR has not yet occurred.30
This can be easily achieved in setting up a quantitative
real-time PCR method by using SYBR Green. We did not
design such primers, and nonspecific amplification has
been observed in our SYBR Green assay, in which non-
specific molecules have been amplified by wild-type-
specific primers after 30 cycles (Ct  30), whereas the
specific product had a Ct of 18.
In the comparison of quantitative real-time PCR meth-
ods with the conventional radioactive PCR/RFLP, it is
remarkable that all of the homoplasmic samples assayed
with the latter method did not result in homoplasmy when
quantified by means of SYBR Green (Table 2). One pos-
sible explanation can be found in the RFLP method itself.
When choosing a restriction endonuclease to digest se-
lectively wild-type or mutant molecules, it should be
noted that the efficiency of the cut is ensured to be
approximately 100%, and different conditions can also
affect digestion, thus generating incomplete digested
products and consequent overestimation of the uncut
molecule.
In our PCR/RFLP assay, we digested the wild-type
molecules, and incomplete digestion overestimated mu-
tant molecules. This can be a plausible explanation, be-
sides the fact that even the proband resulted in hetero-
plasmy. A more exhaustive explanation exists in the fact
that by using the SYBR Green technique associated with
ARMS amplification, the nonspecific amplification of mu-
tant molecules with wild-type primers resulted in an un-
derestimation of “true” wild-type molecules. In fact, we
could have reported as wild-type molecules, in a com-
plex mix like our samples, a mixture of specific wild-type
amplified molecules plus nonspecific mutant molecules,
overestimating the population of total wild-type molecules
amplified using wild-type primers. We did not encounter
the same inconvenience by using the same primers and
technique in the presence of TaqMan probe, probably
because of the specificity of the reaction that further
delayed the appearance of the nonspecific signal.
Quantitative real-time PCR approaches for hetero-
plasmy of different mtDNA point mutations have been
previously reported. Bai and Wong9 used ARMS real-time
PCR in the presence of SYBR Green to quantify hetero-
plasmy of mtDNA 3243A3G mutation, showing good
correlation between the real-time PCR quantitation and
PCR/RFLP analysis. Nomiyama et al22 quantified low
amounts of the same 3243A3G mutation in peripheral
blood of diabetic patients by using ARMS real-time PCR
in the presence of TaqMan probe. They set up the cali-
bration of the method to quantify low amounts of the
mutation (less than 1%). Singh and colleagues24 applied
a quantitative real-time PCR method to quantify the
amount of 3243A3G mutation discriminating wild-type
and mutant molecules by the means of specific TaqMan
probes, comparing the result obtained with the pyrose-
quencing method and fluorescent PCR/RFLP. The three
methods showed detection limits for mutant molecules
less than 1%, thus showing high sensitivity.
We decided to develop such a quantitative method to
evaluate heteroplasmy for one of the primary mutations
responsible for LHON. We focused our efforts to set up a
reproducible method for the follow up of mutational loads
in LHON pedigrees, thus allowing us to follow up LHON
carriers along time. The method we set up showed good
reproducibility and high sensitivity in comparison with the
conventional radioactive PCR/RFLP method, allowing the
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detection of a broad range of mutational load (from 0.01
to 100%), on the basis of in vitro calibration (Figure 3).
The first approach was to design specific primers for
specific amplification of the target sequence, followed by
SYBR Green binding and reporting of the PCR products.
A successful result in this assay was a good correlation
between RFLP analysis and SYBR Green assay, even if
heteroplasmic loads detected using SYBR Green were
lower than the ones obtained by PCR/RFLP for the afore-
mentioned reasons.
The same primers used for SYBR Green experiment
were used in the presence of the TaqMan probe, showing
a good correlation between percentage of TaqMan assay
and RFLP analysis. All homoplasmic samples resulting
from PCR/RFLP analysis were confirmed by real-time
TaqMan assay, except for sample V-3, which was almost
completely homoplasmic (99.8%).
With the very same PCR conditions and primers used,
we showed that in both approaches used in this experi-
ment, the use of specific primers is essential for the
specificity of the reaction: only one mismatch at the 3
end is sufficient for quantitation in the presence of Taq-
Man probe, as demonstrated also by the work of
Nomiyama and colleagues.22 The need of additional mis-
matched nucleotides is essential for the allele-specific
reaction in the presence of SYBR Green, rendering more
feasible the modification of PCR condition for the main-
tenance of primer specificity, as demonstrated by Bai
and Wong.9 In conclusion, both quantitative real-time
PCR techniques are fast and reliable, but the choice of
the allele-specific primers is essential for the reliable
quantitation in both methods.
We believe that the use of real-time quantitative ARMS-
PCR in the presence of TaqMan probe is a fast, precise,
and reliable method for the follow-up of the mutational
load along time of multiple tissues from different individ-
uals of LHON pedigrees, thus allowing a continuous mon-
itoring of the genotype-phenotype correlation within the
same individuals belonging to a specific pedigree.
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